SCHEMBL25660587

SCHEMBL25660587

NC(CCC1CCCCO1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 6/20 0.38
GRIN3B O60391 6/20 0.38
GRIN1 Q05586 6/20 0.38
GRIN2A Q12879 6/20 0.38
GRIN2B Q13224 6/20 0.38
GRIN2C Q14957 6/20 0.38
GRIN3A Q8TCU5 6/20 0.38
GRIK1 P39086 3/20 0.37
GRIK2 Q13002 2/20 0.37
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
GSR P00390 1/20 0.37
CYP1A2 P05177 1/20 0.37
GRM5 P41594 1/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25662308 1.00 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL12028168 0.95 ANPEP (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL18881039 0.90 GSR (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL16360434 0.90 GSR (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL18155642 0.88 GSR (0.42) GSRCYP1A2BLMHPGD
SCHEMBL25660575 0.85 GSR (0.42) GSRCYP1A2ANPEPALDH1A1HPGD
SCHEMBL18281703 0.84 ALDH1A1 (0.39) ALDH1A1KMT2AHPGDHTT
SCHEMBL10187376 0.84 GSR (0.44) GSRCYP1A2ANPEPALDH1A1HPGD
SCHEMBL936034 0.83 GRIN2D (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15249668 0.83 GSR (0.43) GSRCYP1A2ANPEPALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF RAYZEBIO, INC. 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF PAICS, LNPEP, DNPEP GRIN2D 3446/4885GRIN3B 2424/4885GRIN1 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.